Market closed
Jaguar Health/$JAGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jaguar Health
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Ticker
$JAGX
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
49
Website
Jaguar Health Metrics
BasicAdvanced
$3.5M
-
-$130.69
1.11
-
Price and volume
Market cap
$3.5M
Beta
1.11
52-week high
$7.55
52-week low
$4.02
Financial strength
Current ratio
1.634
Quick ratio
0.49
Long term debt to equity
269.395
Total debt to equity
406.794
Interest coverage (TTM)
-133.47%
Management effectiveness
Return on assets (TTM)
-36.99%
Return on equity (TTM)
-565.74%
Valuation
Price to revenue (TTM)
0.131
Price to book
0.38
Price to tangible book (TTM)
-0.25
Price to free cash flow (TTM)
-0.052
Growth
Revenue change (TTM)
19.75%
Earnings per share change (TTM)
-95.12%
3-year revenue growth (CAGR)
39.19%
Jaguar Health News
AllArticlesVideos
Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting
Accesswire·20 hours ago
Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product
Accesswire·1 week ago
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Accesswire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Jaguar Health stock?
Jaguar Health (JAGX) has a market cap of $3.5M as of April 16, 2025.
What is the P/E ratio for Jaguar Health stock?
The price to earnings (P/E) ratio for Jaguar Health (JAGX) stock is 0 as of April 16, 2025.
Does Jaguar Health stock pay dividends?
No, Jaguar Health (JAGX) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Jaguar Health dividend payment date?
Jaguar Health (JAGX) stock does not pay dividends to its shareholders.
What is the beta indicator for Jaguar Health?
Jaguar Health (JAGX) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.